Sanctuary Advisors LLC Makes New $5.53 Million Investment in Ventas, Inc. $VTR

Key Points

• Sanctuary Advisors LLC initiated a $5.53 million position in Ventas during the second quarter by purchasing 62,228 shares. Institutional investors collectively own 94.18% of the healthcare REIT.
• Ventas reported quarterly earnings of $0.97 per share, beating estimates by $0.01, while revenue rose 21.7% year over year to $1.73 billion.
• Analysts maintain a “Moderate Buy” consensus rating, with 15 Buy ratings and three Holds and an average price target of $98, compared with the stock’s reported opening price of $93.47.

Sanctuary Advisors LLC bought a new position in shares of Ventas, Inc. (NYSE:VTR - Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 62,228 shares of the real estate investment trust's stock, valued at approximately $5,526,000.

A number of other large investors have also recently bought and sold shares of the company. Dynamic Wealth Strategies LLC purchased a new position in Ventas during the first quarter valued at approximately $25,000. Wiser Advisor Group LLC purchased a new stake in Ventas in the 3rd quarter worth approximately $27,000. Silvant Capital Management LLC acquired a new stake in shares of Ventas during the 2nd quarter worth approximately $28,000. Meeder Asset Management Inc. acquired a new stake in shares of Ventas during the 2nd quarter worth approximately $30,000. Finally, IFC & Insurance Marketing Inc. purchased a new position in shares of Ventas during the 4th quarter valued at approximately $30,000. Hedge funds and other institutional investors own 94.18% of the company's stock.

Insider Buying and Selling at Ventas

In other news, Director Michael J. Embler bought 2,500 shares of the company's stock in a transaction on Wednesday, June 3rd. The stock was bought at an average cost of $78.81 per share, with a total value of $197,025.00. Following the transaction, the director directly owned 19,202 shares in the company, valued at $1,513,309.62. The trade was a 14.97% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.53% of the company's stock.

Ventas Stock Up 0.4%

Shares of VTR opened at $93.47 on Tuesday. Ventas, Inc. has a 52-week low of $66.38 and a 52-week high of $101.60. The company has a market capitalization of $47.94 billion, a PE ratio of 173.09, a price-to-earnings-growth ratio of 2.15 and a beta of 0.69. The stock has a fifty day simple moving average of $91.56 and a two-hundred day simple moving average of $87.26. The company has a quick ratio of 0.44, a current ratio of 0.44 and a debt-to-equity ratio of 0.86.

Ventas (NYSE:VTR - Get Free Report) last issued its quarterly earnings data on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.96 by $0.01. Ventas had a return on equity of 1.99% and a net margin of 4.08%.The company had revenue of $1.73 billion during the quarter, compared to analyst estimates of $1.68 billion. During the same period in the prior year, the business posted $0.87 earnings per share. The firm's revenue for the quarter was up 21.7% compared to the same quarter last year. As a group, equities analysts forecast that Ventas, Inc. will post 3.89 EPS for the current year.

Wall Street Analyst Weigh In

VTR has been the topic of several recent analyst reports. BMO Capital Markets increased their target price on shares of Ventas from $105.00 to $107.00 and gave the stock an "outperform" rating in a research note on Tuesday, August 11th. Mizuho upped their price target on Ventas from $98.00 to $104.00 and gave the stock an "outperform" rating in a report on Wednesday, July 22nd. KeyCorp increased their price target on Ventas from $90.00 to $95.00 and gave the stock an "overweight" rating in a research report on Thursday, May 7th. Royal Bank Of Canada raised their price objective on Ventas from $98.00 to $99.00 and gave the company an "outperform" rating in a report on Friday, August 14th. Finally, Scotiabank cut their price objective on Ventas from $95.00 to $88.00 and set a "sector perform" rating for the company in a research report on Thursday, June 18th. Fifteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $98.00.

Ventas Profile

Ventas, Inc NYSE: VTR is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas' business model combines property ownership with active asset management and capital markets activity.

Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source